153 related articles for article (PubMed ID: 10400767)
1. Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.
Quan Y; Rong L; Liang C; Wainberg MA
J Virol; 1999 Aug; 73(8):6700-7. PubMed ID: 10400767
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription.
Hooker CW; Lott WB; Harrich D
J Virol; 2001 Apr; 75(7):3095-104. PubMed ID: 11238836
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
Joshi P; Prasad VR
J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Okamoto M; Okamoto T; Baba M
Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
[TBL] [Abstract][Full Text] [Related]
5. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
[TBL] [Abstract][Full Text] [Related]
6. FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.
Sharma KK; Przybilla F; Restle T; Godet J; Mély Y
Nucleic Acids Res; 2016 May; 44(8):e74. PubMed ID: 26762982
[TBL] [Abstract][Full Text] [Related]
7. Sequences in the 5' and 3' R elements of human immunodeficiency virus type 1 critical for efficient reverse transcription.
Ohi Y; Clever JL
J Virol; 2000 Sep; 74(18):8324-34. PubMed ID: 10954531
[TBL] [Abstract][Full Text] [Related]
8. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
[TBL] [Abstract][Full Text] [Related]
9. Development of a human immunodeficiency virus-1 in vitro DNA synthesis system to study reverse transcriptase inhibitors.
Borroto-Esoda K; Boone LR
Antiviral Res; 1994 Apr; 23(3-4):235-49. PubMed ID: 7519003
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
11. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.
Zhang H; Dornadula G; Wu Y; Havlir D; Richman DD; Pomerantz RJ
J Virol; 1996 Jan; 70(1):628-34. PubMed ID: 8523584
[TBL] [Abstract][Full Text] [Related]
13. Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase.
Frankel FA; Marchand B; Turner D; Götte M; Wainberg MA
Antimicrob Agents Chemother; 2005 Jul; 49(7):2657-64. PubMed ID: 15980333
[TBL] [Abstract][Full Text] [Related]
14. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
[TBL] [Abstract][Full Text] [Related]
15. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
Goncalves J; Korin Y; Zack J; Gabuzda D
J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
Witvrouw M; Pannecouque C; Desmyter J; De Clercq E; Andries K
Antiviral Res; 2000 Jun; 46(3):215-21. PubMed ID: 10867159
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.
Maga G; Hübscher U; Pregnolato M; Ubiali D; Gosselin G; Spadari S
Antimicrob Agents Chemother; 2001 Apr; 45(4):1192-200. PubMed ID: 11257034
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function.
Xu HT; Oliveira M; Quan Y; Bar-Magen T; Wainberg MA
J Antimicrob Chemother; 2010 Nov; 65(11):2291-9. PubMed ID: 20852269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
